Key Financial Data Of Reporting Company

TAKARA BIO INC. - Filing #7352210

Concept 2023-04-01 to
2023-12-31
As at
2023-12-31
2023-10-01 to
2023-12-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
29,734,000,000 JPY
78,142,000,000 JPY
60,206,000,000 JPY
Ordinary profit (loss)
586,000,000 JPY
20,682,000,000 JPY
19,480,000,000 JPY
Net assets
112,529,000,000 JPY
112,454,000,000 JPY
114,711,000,000 JPY
Total assets
123,087,000,000 JPY
129,202,000,000 JPY
128,140,000,000 JPY
Basic earnings (loss) per share
1.28
-7.72
132.97
121.21
50.30
Diluted earnings per share
Equity-to-asset ratio
0.912 xbrli:pure
0.869 xbrli:pure
0.893 xbrli:pure
Net cash provided by (used in) operating activities
482,000,000 JPY
36,897,000,000 JPY
13,261,000,000 JPY
Net cash provided by (used in) investing activities
-11,740,000,000 JPY
-6,693,000,000 JPY
-9,551,000,000 JPY
Net cash provided by (used in) financing activities
-5,184,000,000 JPY
-4,119,000,000 JPY
-4,076,000,000 JPY
Cash and cash equivalents
33,761,000,000 JPY
49,058,000,000 JPY
23,212,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.